Loading market dashboard

Financials in USD. Standardized financial statements.
A compact view of how Bionik Laboratories Corp. turns revenue into operating income and net income.
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $1.81M | $1.27M | $1.19M | $2.15M | $3.25M | $987,431 | $571,945 | $0 | $6,000 | $5,200 |
| Revenue Growth? | +41.7% | +6.7% | -44.6% | -33.7% | +228.7% | +72.6% | 0.0% | -100.0% | +15.4% | 0.0% |
| Cost of Revenue? | $815,325 | $320,454 | $269,632 | $893,374 | $1.63M | $402,665 | $388,756 | $63,454 | $7,000 | $0 |
| Gross Profit? | $989,877 | $953,258 | $923,798 | $1.26M | $1.62M | $584,766 | $183,189 | -$63,454 | -$1,000 | $5,200 |
| Gross Margin? | +54.8% | +74.8% | +77.4% | +58.5% | +49.8% | +59.2% | +32.0% | 0.0% | -16.7% | +100.0% |
| Operating Expenses? | $5.81M | $5.73M | $7.08M | $12.42M | $11.10M | $10.35M | $8.83M | $6.63M | $28,528 | $18,309 |
| Operating Income? | -$4.83M | -$4.77M | -$6.16M | -$11.25M | -$7.29M | -$10.04M | -$7.95M | -$6.63M | -$29,528 | -$13,109 |
| EBITDA? | -$4.78M | -$9.48M | -$13.03M | -$24.45M | -$6.94M | -$9.73M | -$7.40M | -$6.57M | -$29,528 | -$13,109 |
| Income Before Tax | -$4.95M | -$10.41M | -$13.62M | -$25.02M | -$10.56M | -$14.63M | -$3.94M | $1.04M | -$29,528 | -$13,109 |
| Income Tax Expense | $0 | $0 | $0 | $0 | -$507 | $103,000 | -$4.06M | -$7.67M | $0 | $0 |
| Net Income? | -$4.95M | -$10.41M | -$13.62M | -$24.93M | -$10.56M | -$14.73M | -$3.94M | $1.04M | -$29,528 | -$13,109 |
| EPS? | $-0.72 | $-1.78 | $-2.66 | $-5.60 | $-4.47 | $-21.88 | $-6.43 | $2.17 | $-0.06 | $-0.02 |
| Diluted EPS? | $-0.72 | $-1.78 | $-2.66 | $-5.60 | $-4.47 | $-21.88 | $-6.43 | $1.94 | $-0.06 | $-0.02 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality